$MDWD
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
Healthcare
Sector
Biotechnology
Industry
Ofer Gonen
CEO
111
Employees
$14.45
Current Price
$204.11M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 2 | 5 | $133,896.19 | 9,537 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 weeks | Buys | 3 | 6 | $136,045.69 | 9,687 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 1 month | Buys | 3 | 6 | $136,045.69 | 9,687 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 2 months | Buys | 3 | 6 | $136,045.69 | 9,687 | All Buys |
| Sells | 0 | 0 | - | - | ||
| 3 months | Buys | 3 | 6 | $136,045.69 | 9,687 | All Buys |
| Sells | 0 | 0 | - | - | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
| Date | Insider | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | SHAMIR NACHUM Director | Purchase | 175 | $13.97 | $2,445.62 | View Details |
| Jun 3, 2026 | SHAMIR NACHUM Director | Purchase | 5,825 | $14.00 | $81,550.00 | View Details |
| Jun 1, 2026 | Fox David Morton Director | Purchase | 1,730 | $14.22 | $24,609.25 | View Details |
| Jun 1, 2026 | Fox David Morton Director | Purchase | 1,797 | $13.99 | $25,149.01 | View Details |
| Jun 1, 2026 | Fox David Morton Director | Purchase | 10 | $14.23 | $142.30 | View Details |
| May 29, 2026 | Rubinstein Samuel Director | Purchase | 150 | $14.33 | $2,149.50 | View Details |
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated-$0.60
ActualN/A
Revenue
EstimatedN/A
ActualN/A
Related Activity
Cross-company insider connections and cluster buy signals
Insiders Also Active At
Insiders at this company also hold positions or have traded at these companies: